Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus

Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C

(2009) B. J. Veldt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

(2009) Anna S. Lok et al.   HEPATOLOGY

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients

(2009) Patrizia Burra et al.   LIVER TRANSPLANTATION

Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways

(2009) Kim R. Bridle et al.   LIVER TRANSPLANTATION

Insulin Resistance and Diabetes Increase Fibrosis in the Liver of Patients With Genotype 1 HCV Infection

(2008) Salvatore Petta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C

(2008) Ian Homer Y. Cua et al.   HEPATOLOGY

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

(2008) Raj Vuppalanchi et al.   HEPATOLOGY

The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation

(2008) Ibrahim A. Hanouneh et al.   LIVER TRANSPLANTATION

Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis

(2008) Javier Briceño et al.   LIVER TRANSPLANTATION

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

(2007) Rami Moucari et al.   GASTROENTEROLOGY